# EDGAR Filing Document

**Accession Number:** 0001675107
**File Stem:** 0001243786-23-000023
**Filing Date:** 2023-3
**Character Count:** 6910
**Document Hash:** 8630115f16358732e9638d2fa6e0b000
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001243786-23-000023.hdr.sgml**: 20230307

**ACCESSION NUMBER**: 0001243786-23-000023

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20230305

**FILED AS OF DATE**: 20230307

**DATE AS OF CHANGE**: 20230307

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Bodine Bruce M.
- **CENTRAL INDEX KEY:** 0001675107

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-32327
- **FILM NUMBER:** 23714669

**MAIL ADDRESS:**
- **STREET 1:** C/O THE MOSAIC COMPANY
- **STREET 2:** 101 EAST KENNEDY BLVD., SUITE 2500
- **CITY:** TAMPA
- **STATE:** FL
- **ZIP:** 33602
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** MOSAIC CO
- **CENTRAL INDEX KEY:** 0001285785
- **STANDARD INDUSTRIAL CLASSIFICATION:** AGRICULTURE CHEMICALS [2870]
- **IRS NUMBER:** 201026454
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 101 EAST KENNEDY BLVD.
- **STREET 2:** SUITE 2500
- **CITY:** TAMPA
- **STATE:** FL
- **ZIP:** 33602
- **BUSINESS PHONE:** 813-775-4200

**MAIL ADDRESS:**
- **STREET 1:** 101 EAST KENNEDY BLVD.
- **STREET 2:** SUITE 2500
- **CITY:** TAMPA
- **STATE:** FL
- **ZIP:** 33602

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** GLOBAL NUTRITION SOLUTIONS INC
- **DATE OF NAME CHANGE:** 20040401

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Bodine Bruce M.<br><sub>(Last) (First) (Middle)</sub><br>C/O THE MOSAIC COMPANY<br>101 EAST KENNEDY BLVD., SUITE 2500<br><sub>(Street)</sub><br>TAMPA, FL 33602<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2023-03-05 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [ ] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_Senior VP - North America_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>MOSAIC CO [ MOS ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Common Stock | 2023-03-05 |  | M |  | 24707 | A | $0 | 91628 | D |  |
| Common Stock | 2023-03-05 |  | M<sup>(1)</sup> |  | 103489 | A | $0 | 195117 | D |  |
| Common Stock | 2023-03-05 |  | F<sup>(2)</sup> |  | 50509 | D | $57.14 | 144608 | D |  |
| Common Stock |  |  |  |  |  |  |  | 702.938 | I | By 401(k) Plan |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Stock Option (Right to Buy) | $28.49 |  |  |  |  |  |  | <sup>(3)</sup> | 2026-03-03 | Common Stock | 17921.0 |  | 17921 | D |  |
| Stock Option (Right to Buy) | $30.42 |  |  |  |  |  |  | <sup>(3)</sup> | 2027-03-02 | Common Stock | 25227.0 |  | 25227 | D |  |
| Restricted Stock Units | 0.0<sup>(4)</sup> | 2023-03-05 |  | M |  |  | 24707 | 2023-03-05 | <sup>(5)</sup> | Common Stock | 24707.0 | $0 | 0 | D |  |
| Restricted Stock Units | 0.0<sup>(4)</sup> |  |  |  |  |  |  | 2024-03-04 | <sup>(5)</sup> | Common Stock | 18036.0 |  | 18036 | D |  |
| Restricted Stock Units | 0.0<sup>(4)</sup> |  |  |  |  |  |  | 2025-03-03 | <sup>(5)</sup> | Common Stock | 12217.0 |  | 12217 | D |  |

---

### Footnotes:

(1) Shares issued to reporting person upon the vesting of a performance unit award granted to reporting person on March 5, 2020.  The performance unit award was not a derivative security.

(2) Shares sold to cover tax liability incurred as a result of most recent vesting of restricted stock and performance units.

(3) This Stock Option is 100% exercisable.

(4) One-for-One

(5) Not Applicable

**Signature:** /s/ Philip E. Bauer, Attorney-in-Fact for Bruce M. Bodine  
**Date:** 2023-03-07

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**